NCT02968433View on ClinicalTrials.gov

The Stanford Parkinson's Disease Plasma Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Parkinson Disease(PD)
Interventions
DRUG

Infusions of young plasma

Participants will receive four twice- weekly infusions of 1 unit young plasma (male, ages between 18-25)

Trial Locations (1)

94304

Stanford Movement Disorders Clinic, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02968433 - The Stanford Parkinson's Disease Plasma Study | Biotech Hunter | Biotech Hunter